B. Trausch

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotype

U. Hofmann, M. Eichelbaum, G. Mikus, 1997, Clinical pharmacology and therapeutics.

Nerve ultrasound in the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis with predominant lower motor neuron disease (ALS/LMND)

A. Storch, A. Hermann, J. Machetanz, 2015, Journal of Neurology.

Elucidation of the structure of talinolol metabolites in man. Determination of talinolol and hydroxylated talinolol metabolites in urine and analysis of talinolol in serum.

W. Kirch, R. Oertel, T. Gramatté, 1994, Journal of chromatography. B, Biomedical applications.

Disposition and bioavailability of the β1‐adrenoceptor antagonist talinolol in man

R. Oertel, T. Gramatté, K. Richter, 1995, Biopharmaceutics & drug disposition.

[A quick, simple HPLC method for determination of talinolol in serum].

R. Oertel, T. Gramatté, K. Richter, 1994, Die Pharmazie.

DISPOSITION AND BIOAVAILABILITY OF TALINOLOL IN MAN* THE PI-ADRENOCEPTOR ANTAGONIST

R. Oertel, T. Gramatté, K. Richter, 2005 .